Particulate matter increases bone morphogenetic protein 2 in lung fibroblasts

Area of Science:

• Environmental Health
• Cell Biology
• Pulmonary Medicine

Background:

• Particulate matter < 2.5 µm (PM2.5) is linked to chronic respiratory disorders, but underlying mechanisms remain unclear.
• Lung fibroblast responses to PM2.5 are less understood than epithelial cell responses.
• Bone morphogenetic protein 2 (BMP2) is a key mediator in lung disease pathogenesis, including fibrosis and COPD.

Purpose of the Study:

• To investigate the impact of PM2.5 on fibroblast BMP2 production.
• To determine BMP2's role in fibroblast-to-myofibroblast differentiation and matrix generation.
• To elucidate PM2.5's mechanism in contributing to lung disease.

Main Methods:

• Fibroblast treatment with varying concentrations of PM2.5.
• Quantification of BMP2 mRNA and protein expression.
• Assessment of collagen and α-smooth muscle actin expression.
• Analysis of p38 and ERK1/2 phosphorylation.
• BMP2 silencing and use of BMP2 antagonist (gremlin).

Main Results:

• PM2.5 induced a dose-dependent increase in fibroblast BMP2 mRNA and protein.
• BMP2 differentially regulated collagen and α-smooth muscle actin expression in quiescent fibroblasts versus myofibroblasts.
• High PM2.5 concentrations suppressed fibroblast activation and matrix production, an effect reversed by BMP2 inhibition.

Conclusions:

• PM2.5 exposure upregulates BMP2 production in lung fibroblasts.
• PM2.5-induced BMP2 contributes to the suppression of fibroblast activation and matrix production.
• This mechanism highlights how PM2.5 may impair lung fibroblast repair capabilities, contributing to lung disease.